119 related articles for article (PubMed ID: 38867461)
21. Diaphragm muscle fibrosis involves changes in collagen organization with mechanical implications in Duchenne muscular dystrophy.
Sahani R; Wallace CH; Jones BK; Blemker SS
J Appl Physiol (1985); 2022 Mar; 132(3):653-672. PubMed ID: 35050792
[TBL] [Abstract][Full Text] [Related]
22. Respiratory characterization of a humanized Duchenne muscular dystrophy mouse model.
Roger AL; Biswas DD; Huston ML; Le D; Bailey AM; Pucci LA; Shi Y; Robinson-Hamm J; Gersbach CA; ElMallah MK
Respir Physiol Neurobiol; 2024 Aug; 326():104282. PubMed ID: 38782084
[TBL] [Abstract][Full Text] [Related]
23. N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice.
Whitehead NP; Pham C; Gervasio OL; Allen DG
J Physiol; 2008 Apr; 586(7):2003-14. PubMed ID: 18258657
[TBL] [Abstract][Full Text] [Related]
24. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
25. Impaired respiratory function in mdx and mdx/utrn(+/-) mice.
Huang P; Cheng G; Lu H; Aronica M; Ransohoff RM; Zhou L
Muscle Nerve; 2011 Feb; 43(2):263-7. PubMed ID: 21254093
[TBL] [Abstract][Full Text] [Related]
26. Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice.
Terrill JR; Boyatzis A; Grounds MD; Arthur PG
Int J Biochem Cell Biol; 2013 Sep; 45(9):2097-108. PubMed ID: 23892094
[TBL] [Abstract][Full Text] [Related]
27. Nutraceutical and pharmaceutical cocktails did not preserve diaphragm muscle function or reduce muscle damage in D2-mdx mice.
Spaulding HR; Quindry T; Quindry JC; Selsby JT
Exp Physiol; 2020 Jun; 105(6):989-999. PubMed ID: 32267561
[TBL] [Abstract][Full Text] [Related]
28. Tempol Supplementation Restores Diaphragm Force and Metabolic Enzyme Activities in mdx Mice.
Burns DP; Ali I; Rieux C; Healy J; Jasionek G; O'Halloran KD
Antioxidants (Basel); 2017 Dec; 6(4):. PubMed ID: 29210997
[TBL] [Abstract][Full Text] [Related]
29. Long-term human IgG treatment improves heart and muscle function in a mouse model of Duchenne muscular dystrophy.
Zschüntzsch J; Jouvenal PV; Zhang Y; Klinker F; Tiburcy M; Liebetanz D; Malzahn D; Brinkmeier H; Schmidt J
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1018-1031. PubMed ID: 32436338
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
31. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy.
Mucha O; Podkalicka P; Kaziród K; Samborowska E; Dulak J; Łoboda A
Skelet Muscle; 2021 Sep; 11(1):21. PubMed ID: 34479633
[TBL] [Abstract][Full Text] [Related]
33. Evidence of hypoxic tolerance in weak upper airway muscle from young mdx mice.
Burns DP; O'Halloran KD
Respir Physiol Neurobiol; 2016 Jun; 226():68-75. PubMed ID: 26691169
[TBL] [Abstract][Full Text] [Related]
34. Myofibrillar Lattice Remodeling Is a Structural Cytoskeletal Predictor of Diaphragm Muscle Weakness in a Fibrotic
Ritter P; Nübler S; Buttgereit A; Smith LR; Mühlberg A; Bauer J; Michael M; Kreiß L; Haug M; Barton E; Friedrich O
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142754
[TBL] [Abstract][Full Text] [Related]
35. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
[TBL] [Abstract][Full Text] [Related]
36. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
37. Combined XIL-6R and urocortin-2 treatment restores MDX diaphragm muscle force.
Manning J; Buckley MM; O'Halloran KD; O'Malley D
Muscle Nerve; 2017 Dec; 56(6):E134-E140. PubMed ID: 28294390
[TBL] [Abstract][Full Text] [Related]
38. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
[TBL] [Abstract][Full Text] [Related]
39. The Effects of Experimental Sleep Apnea on Cardiac and Respiratory Functions in 6 and 18 Month Old Dystrophic (mdx) Mice.
Chaudhari MR; Fallavollita JA; Farkas GA
PLoS One; 2016; 11(1):e0147640. PubMed ID: 26808526
[TBL] [Abstract][Full Text] [Related]
40. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
